Michelle Xia

Michelle Xia

Chief Executive Officer chez AKESO, INC.

Fortune : 256 M $ au 31/03/2024

58 ans
Health Technology
Consumer Services
Commercial Services

Profil

Yu Xia is the founder of Zhongshan Kangfang Biopharma Co. Ltd.
(founded in 2012) and Akeso, Inc. (founded in 2012), where she holds the titles of President & Chief Executive Officer and Chairman, President & Chief Executive Officer, respectively.
Currently, she is a Director at Summit Therapeutics, Inc. (since 2023) and holds the position of General Manager at AD Pharmaceuticals Co., Ltd.
She previously worked as Chairman & General Manager at Akeso Pharmaceuticals CJSC, Principal at Bayer Healthcare LLC, Senior Vice President at Crown Bioscience, Inc. (from 2008 to 2012), and Principal at PDL BioPharma, Inc. Dr. Xia holds a doctorate degree from Newcastle University (conferred in 1994) and an undergraduate degree from Sun Yat-Sen University (conferred in 1988).

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
09/02/2024 31 523 530 ( 4,49% ) 131 M $ 31/03/2024
28/03/2024 21 000 000 ( 2,50% ) 125 M $ 31/03/2024

Postes actifs de Michelle Xia

SociétésPosteDébut
AKESO, INC. Chief Executive Officer 16/11/2019
SUMMIT THERAPEUTICS INC. Director/Board Member 16/01/2023
Chief Executive Officer 01/03/2012
Chief Executive Officer -
Tous les postes actifs de Michelle Xia

Anciens postes connus de Michelle Xia

SociétésPosteFin
Corporate Officer/Principal 01/03/2012
PDL BIOPHARMA, INC. Corporate Officer/Principal -
Corporate Officer/Principal -
Chairman -
Voir l'expérience en détail de Michelle Xia

Formation de Michelle Xia

Newcastle University Doctorate Degree
Sun Yat-Sen University Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Michelle Xia

Relations

98

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
SUMMIT THERAPEUTICS INC.

Health Technology

AKESO, INC.

Health Technology

Entreprise privées6

Health Technology

Commercial Services

Health Technology

Distribution Services

Health Technology

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Michelle Xia